Cigna Group Shares Are On The Rise Friday: What's Going On?

Comments
Loading...
Zinger Key Points

Cigna Group inc. CI shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.

What To Know: Cigna reported fourth-quarter revenue of $65.68 billion, exceeding analyst estimates of $63.36 billion, but missed on earnings with an adjusted EPS of $6.64 versus expectations of $7.82. The earnings shortfall was driven by higher stop-loss medical costs, which contributed to an 8% decline in adjusted income from operations.

Despite the earnings miss, revenue grew 27% year-over-year, led by increases in pharmacy benefit services and specialty care. The company also announced a $6 billion increase to its share repurchase program, bringing total authorization to $10.3 billion.

Cigna provided 2025 guidance, expecting at least $252 billion in revenue, slightly above estimates. However, full-year adjusted EPS guidance of at least $29.50 fell short of analysts’ expectations of $31.50.

Shares initially dropped 11.1% on Thursday but are rebounding potentially as investors focus on management's corrective actions and long-term strategy.

CI Price Action: Cigna Group shares were up 4.97% at $297.04 at the time of writing, according to Benzinga Pro.

Read Next:

Image Via Shutterstock.

CI Logo
CIThe Cigna Group
$307.99-4.47%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum53.14
Growth66.68
Quality40.22
Value29.00
Price Trend
Short
Medium
Long
Got Questions? Ask
Which pharmacy benefit managers might gain from Cigna's growth?
How will insurance providers react to Cigna's earnings miss?
Are there healthcare ETFs that could benefit from Cigna's strategy?
What medical service sectors may thrive with Cigna's revenue boost?
How could Cigna's share repurchase program impact investor sentiment?
What competitors might be affected by Cigna's market performance?
Will specialty care companies see increased demand due to Cigna's growth?
What stock analysts are revising their outlook on Cigna?
Which dividend stocks could benefit from Cigna's share buyback?
How might Cigna's long-term strategy influence healthcare investments?
Market News and Data brought to you by Benzinga APIs

Posted In: